ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRN Amarin Corp PLC

0.88
0.0357 (4.23%)
25 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Amarin Corp PLC AMRN NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.0357 4.23% 0.88 09:59:40
Open Price Low Price High Price Close Price Previous Close
0.90 0.84 0.90 0.8475 0.8443
more quote information »

Recent News

Date Time Source Heading
06/5/202422:00GLOBEAmarin to Present at H.C. Wainwright 2nd Annual BioConnect..
01/5/202421:00GLOBE Amarin Reports First Quarter 2024 Business Update and..
25/4/202404:00GLOBEAmarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA..
22/4/202422:00GLOBEAmarin Announces Results of Annual General Meeting of..
15/4/202422:00GLOBEAmarin to Report First Quarter 2024 Financial Results and..
08/4/202422:00GLOBEAmarin Highlights Key Data Providing Mechanistic Insights..
08/4/202420:30PRNCANew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl)..
07/4/202405:30GLOBENew REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent..
03/4/202423:00GLOBEAmarin Provides Update on VAZKEPA® (Icosapent Ethyl)..
25/3/202423:00GLOBEResearch Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent..
05/3/202409:30EDGAR2Form ARS - Annual Report to Security Holders
05/3/202400:00EDGAR2Form DEF 14A - Other definitive proxy statements
29/2/202423:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202423:05EDGAR2Form 8-K - Current report
29/2/202423:00GLOBEAmarin Reports Fourth Quarter and Full Year 2023 Financial..
16/2/202400:00GLOBEAmarin to Report Fourth Quarter and Full Year 2023 Financial..
13/2/202400:00EDGAR2Form PRE 14A - Other preliminary proxy statements
10/2/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:00EDGAR2Form 8-K - Current report
25/1/202408:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:30GLOBEAmarin Chairman & CEO Issue Letter to Shareholders
13/1/202409:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202409:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202409:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202423:00EDGAR2Form 8-K - Current report
10/1/202423:00GLOBEAmarin Provides Preliminary Fourth Quarter 2023 Selected..
09/1/202410:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202410:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202408:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202310:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202308:20EDGAR2Form 144 - Report of proposed sale of securities
12/12/202300:00GLOBEAmarin to Present at the 42nd Annual J.P. Morgan Healthcare..
06/12/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:30EDGAR2Form SC 13D/A - General statement of acquisition of..
13/11/202301:00GLOBENew REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl)..
04/11/202307:30EDGAR2Form 8-K - Current report
01/11/202322:05EDGAR2Form 8-K - Current report
01/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202322:00GLOBEAmarin Reports Third Quarter 2023 Financial Results
01/11/202307:05EDGAR2Form 8-K - Current report
01/11/202303:00GLOBEAmarin Appoints Jonathan Provoost Executive Vice President,..
26/10/202323:00GLOBELatest Research Evaluating VASCEPA®/VAZKEPA® (icosapent..
19/10/202323:00GLOBE Amarin to Report Third Quarter 2023 Financial Results and..
12/9/202322:00GLOBEAmarin to Present at the 2023 Cantor Global Healthcare..

Your Recent History

Delayed Upgrade Clock